Preparation method of sevoflurane

By using a sodium aluminosilicate molecular sieve with a high silicon-aluminum ratio in the preparation of heptafluorane, the problem of difficulty in removing impurities in the prior art is solved, and the purity of the product and industrial applicability are improved.

CN119039100AInactive Publication Date: 2024-11-29JIANGSU HENGRUI MEDICINE CO LTD +1

Patent Information

Application Number
CN202411523960.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-30
Publication Date
2024-11-29
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing heptafluorane preparation process has low yields and is difficult to remove impurities, especially the properties of impurities A, B and C are similar to those of heptafluorane, which leads to high distillation and purification costs and is difficult to achieve high purity.

Method used

Chloromethyl hexafluoroisopropyl ether is prepared by reaction of hexafluoroisopropyl alcohol, chlorination reagent and methylation reagent, and then react with fluoride to form a crude hexafluoroane product, and by using sodium aluminosilicate with a silicon-alumino-silicate ratio greater than 200 The molecular sieve is separated and further processed by distillation and rectification to improve purity.

Benefits of technology

It significantly reduces the impurity content in the finished heptaflurane product, improves product purity, simplifies the operating process, is suitable for industrial production, and reduces purification costs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_2
    Figure SMS_2
Patent Text Reader

Abstract

The invention relates to a preparation method of sevoflurane. The preparation method of sevoflurane comprises the following steps: mixing hexafluoroisopropanol, a chlorination reagent and a methylation reagent for reaction to prepare chloromethyl hexafluoroisopropyl ether; a step of reacting chloromethyl hexafluoroisopropyl ether with fluoride to prepare a sevoflurane crude product; and mixing the sevoflurane crude product with the sodium aluminosilicate molecular sieve, and then separating to obtain a sevoflurane finished product. The method disclosed by the invention is simple and convenient to operate, high in purification efficiency and more suitable for industrial production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of medicine and relates to a method for preparing sevoflurane. Background Art

[0002] Sevoflurane (fluoromethyl-1, 1, 1, 3, 3, 3-hexafluoroisopropyl ether) is a halogenated volatile anesthetic that is widely used in clinical practice due to its rapid onset of action and few side effects.

[0003] US3683092 reports a method for preparing sevoflurane, wherein hexafluoroisopropyl methyl ether is reacted with chlorine under light to obtain an intermediate chloromethyl hexafluoroisopropyl ether, which is further reacted to generate sevoflurane.

[0004] US6100434 discloses a method for synthesizing sevoflurane. First, hexafluoroisopropanol and polyoxymethylene (or 1,3,5-trioxane) are reacted in the presence of a chlorinating agent to obtain chloromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether, and then the chloromethyl ether is reacted with a fluorinated reagent to obtain sevoflurane.

[0005] The current process for preparing sevoflurane generally has a low yield and produces a variety of impurities, some of which have properties similar to those of sevoflurane. Distillation is a commonly used method for refining sevoflurane, but even if the impurities are removed by distillation purification, the sevoflurane product still contains some impurities that are difficult to remove. According to the European Pharmacopoeia, the main impurities of sevoflurane are the following impurities A, impurity B and impurity C. These impurities are difficult to remove and the purification cost is high.

[0006] . Summary of the invention

[0007] On one hand, the present disclosure provides a method for preparing sevoflurane, comprising: a step of preparing chloromethyl hexafluoroisopropyl ether by mixing hexafluoroisopropanol, a chlorination agent and a methylation agent; a step of preparing a crude sevoflurane product by reacting chloromethyl hexafluoroisopropyl ether with a fluoride; and a step of mixing the crude sevoflurane product with a sodium aluminosilicate molecular sieve, and then separating to obtain a finished sevoflurane product, wherein the sodium aluminosilicate molecular sieve has a silicon to aluminum ratio greater than 200.

[0008] Sodium aluminosilicate molecular sieve refers to aluminosilicate zeolite materials containing silicon, aluminum and sodium elements, and its chemical composition mainly includes sodium oxide (Na2O), aluminum oxide (Al2O3) and silicon oxide (SiO2). Conventional sodium aluminosilicate molecular sieves generally have a small silicon-aluminum ratio. For example, the silicon-aluminum ratio of 13X molecular sieve, 3A molecular sieve and 4A molecular sieve, which are not specifically specified, is generally between 2-3.

[0009] In some embodiments, the silicon to aluminum ratio of the molecular sieve can be 200, 210, 220, 230, 240, 250, 260, 270, 280, 290, 300, 310, 320, 330, 340, 350, 360, 370, 380, 390, 400, 420, 440, 460, 480, 500, 550, 600, 650, 700, 750, 800, 850, 900, 950, 1000, 1500, 2000, and any range between these point values. In some embodiments, the silicon to aluminum ratio of the molecular sieve can be 200-1500.

[0010] In some embodiments, the pore size of the molecular sieve is no greater than 5 angstroms, such as no greater than 4 angstroms.

[0011] In some embodiments, the molecular sieve is a modified version of 4A molecular sieve.

[0012] In some embodiments, the method further comprises the step of subjecting the crude sevoflurane to distillation. In some embodiments, the method further comprises the step of subjecting the crude sevoflurane to rectification.

[0013] In some embodiments, the method further comprises the steps of subjecting the crude sevoflurane to distillation, purifying it by rectification, and collecting the crude sevoflurane fraction.

[0014] In some embodiments, the chlorination agent may be aluminum trichloride or phosphorus trichloride. The molar ratio of the chlorination agent to hexafluoroisopropanol is 1:1 to 1.4:1.

[0015] The methylating agent can be a conventional methylating agent, for example, one or more of formaldehyde, trioxymethylene, and polyformaldehyde. The molar ratio of the methylating agent to hexafluoroisopropanol is 1:1 to 1.2:1.

[0016] The reaction temperature is not particularly limited and can be 0 to 35°C.

[0017] In some embodiments, the reaction solvent for preparing chloromethyl hexafluoroisopropyl ether comprises chloromethyl hexafluoroisopropyl ether. The reaction solvent comprising chloromethyl hexafluoroisopropyl ether means that chloromethyl hexafluoroisopropyl ether is present in the reaction system as a solvent at the beginning of the reaction. The reaction solvent may also comprise other conventional solvents.

[0018] In some embodiments, concentrated sulfuric acid is not added to the reaction.

[0019] In some embodiments, no strong acid is added in the reaction. The strong acid may be one or more of concentrated sulfuric acid, oleum, concentrated phosphoric acid, and trifluoromethanesulfonic acid.

[0020] In some embodiments, the method for preparing crude sevoflurane comprises the step of reacting chloromethyl hexafluoroisopropyl ether with a fluoride, wherein the reaction can be carried out in the presence or absence of a catalyst, and the catalyst can be an ether, a polyether, a crown ether, an alcohol or a polyhydroxy compound, for example, ethylene glycol, 18-crown-6, diethylene glycol, triethylene glycol, pentaerythritol, 1,2,3-propanetriol, any one or a combination of tris(2-hydroxyethyl)amine and a polyhydroxy sugar compound, and the polyhydroxy sugar compound can be mannitol, erythritol or sorbitol. For example, the catalyst can be one or more of pentaerythritol or 1,2,3-propanetriol. The amount of the catalyst can be 3% to 80% of the weight of the chloromethyl hexafluoroisopropyl ether.

[0021] In some embodiments, the fluoride is selected from metal fluorides such as calcium fluoride, potassium fluoride, sodium fluoride, cesium fluoride or ammonium fluoride, or other fluoride salts that exist in solid form under normal conditions, such as potassium fluoride. The molar ratio between chloromethyl hexafluoroisopropyl ether and fluoride is selected from 1: 1 to 1: 5.

[0022] The reaction of chloromethyl hexafluoroisopropyl ether and fluoride can be carried out in the absence of a solvent or in the presence of a reaction solvent, wherein the reaction solvent can be one or more of polyethylene glycol, cyclopentane sulfone, N, N'-dimethylformamide, N, N'-dimethylacetamide, dimethyl sulfoxide or water, for example, one or more of polyethylene glycol, cyclopentane sulfone or water.

[0023] In some embodiments, the method includes: 1) mixing hexafluoroisopropanol, aluminum chloride and paraformaldehyde to prepare chloromethyl hexafluoroisopropyl ether; 2) reacting chloromethyl hexafluoroisopropyl ether with potassium fluoride and pentaerythritol to obtain a product, and separating the product by distillation to prepare a crude sevoflurane product; 3) mixing the crude sevoflurane product with a sodium aluminosilicate molecular sieve having a silicon-aluminum ratio greater than 200, and then separating to obtain a finished sevoflurane product.

[0024] In some embodiments, the content of impurity A in the finished sevoflurane product is less than 5 µg / g, for example, less than 4 µg / g, 3 µg / g, 2 µg / g, or 1 µg / g.

[0025] In some embodiments, the content of impurity B in the finished sevoflurane product is less than 3 µg / g, such as less than 2 µg / g or 1 µg / g.

[0026] In some embodiments, the content of impurity C in the finished sevoflurane product is less than 50 μg / g, for example, less than 40 μg / g, 30 μg / g, 20 μg / g, or 10 μg / g.

[0027] The method for refining sevoflurane disclosed in the present invention uses a molecular sieve with a specific silicon-aluminum ratio to treat a crude sevoflurane product, so that the content of related impurities in the finished product is significantly reduced, the purity of the product is greatly improved, and the product quality of the finished sevoflurane product is improved. At the same time, the molecular sieve treatment method is easy to operate, has high purification efficiency, and is more suitable for industrial production.

[0028] The molecular sieves with different silicon-aluminum ratios described in the present disclosure can be prepared by methods disclosed in the prior art. For example, Su Jianming, Liu Wenbo, Liu Jianli, et al. Petroleum Refining and Chemical Engineering, 2004, 35(4):5; Liu Lijie, Hu Yunfeng, Shu Jing. Industrial Catalysis, 2014, 22(6):7, etc., which are all cited in their entirety.

[0029] The impurity content in the sevoflurane disclosed in the present invention can be detected by gas chromatography. The detection method can refer to the existing technology or the methods disclosed in the pharmacopoeias of various countries, such as the methods described in EP1165478B, CN103635451A, etc. DETAILED DESCRIPTION

[0030] The present disclosure will be explained in detail below in conjunction with specific examples so that those skilled in the art can have a more comprehensive understanding of the present disclosure. The specific examples are only used to illustrate the technical solutions of the present disclosure and do not limit the present disclosure in any way.

[0031] Example 1

[0032] Step 1: Synthesis of Chloromethyl Hexafluoroisopropyl Ether

[0033] Add 310kg aluminum chloride and 210kg solvent chloromethyl hexafluoroisopropyl ether to a 1000L reactor, cool to -5℃~0℃, add 300kg hexafluoroisopropanol dropwise while stirring, continue stirring for 0.5 hours after the addition, then add 56.8kg paraformaldehyde, and stir until the reaction is complete. Cool below 0℃, add 600L 6mol / L hydrochloric acid dropwise, separate the organic layer, and wash twice with 600L water to obtain 350.9kg chloromethyl hexafluoroisopropyl ether with a GC purity of 99.0%.

[0034] Step 2: Synthesis of crude sevoflurane

[0035] In a 1000L reactor, add 450kg sulfolane, 105kg potassium fluoride and 30kg pentaerythritol, then add 140kg chloromethyl hexafluoroisopropyl ether and 25kg purified water. Heat and react at 97-102℃ until the reaction is complete, cool and add 150kg purified water, distill to obtain 105.2kg of crude sevoflurane, and rectify to obtain 64.5kg of crude sevoflurane with a GC purity of 99.98%. Among them, the content of impurity A is 8.9 µg / g, the content of impurity B is 4.7 µg / g, and the content of impurity C is 93.2 µg / g.

[0036] Example 2 Purification of sevoflurane

[0037] Take 100 g of the crude sevoflurane obtained in Example 1, add 3 g of molecular sieves of different types thereto, stir for 5 minutes, let stand for 12 hours, stir for another 5 minutes, filter, and obtain the finished sevoflurane.

[0038] The impurity content of the finished product of sevoflurane was analyzed by GC, as shown in the following table. Among them, the improved 4A molecular sieve 4A-G molecular sieve increases the silicon-aluminum ratio of the molecular sieve by increasing the feed amount of raw silicon dioxide in the process of preparing the 4A molecular sieve.

[0039]

[0040] It can be seen from the above table that after using conventional molecular sieves to treat crude sevoflurane, a large amount of impurities still remain in sevoflurane, and ordinary molecular sieves have basically no ability to purify impurities A, impurity B and impurity C. However, when the silicon-aluminum ratio of the molecular sieve is increased to more than 200, the contents of the three impurities in the treated sevoflurane are significantly reduced, greatly improving the product quality of sevoflurane.

[0041] Since the disclosure has been described in terms of specific embodiments thereof, certain modifications and equivalent changes will be apparent to one skilled in the art and are intended to be included within the scope of the disclosure.

Claims

1. A method for preparing sevoflurane, include: The step of preparing chloromethyl hexafluoroisopropyl ether by mixing hexafluoroisopropanol, a chlorinating agent and a methylating agent; The step of preparing a crude sevoflurane product by reacting chloromethyl hexafluoroisopropyl ether with a fluoride; and the step of mixing the crude sevoflurane with sodium aluminosilicate molecular sieve and then separating to obtain the finished sevoflurane product, Wherein, the silicon-aluminum ratio of the sodium aluminosilicate molecular sieve is greater than 200.

2. The preparation method according to claim 1, wherein the silicon-aluminum ratio of the molecular sieve is 200-1500.

3. The preparation method according to claim 1, further comprising the step of subjecting the product prepared by the reaction of chloromethyl hexafluoroisopropyl ether and fluoride to distillation to obtain a crude sevoflurane product.

4. The preparation method according to claim 1, wherein the chlorinating agent is aluminum chloride or phosphorus chloride.

5. The preparation method according to claim 1, wherein the methylating agent is selected from one or more of formaldehyde, trioxymethylene and paraformaldehyde.

6. The preparation method according to claim 1, wherein the reaction solvent for preparing chloromethyl hexafluoroisopropyl ether comprises chloromethyl hexafluoroisopropyl ether.

7. The preparation method according to claim 1, wherein the fluoride is calcium fluoride, potassium fluoride, sodium fluoride, cesium fluoride or ammonium fluoride.

8. The preparation method according to claim 1, wherein in the step of preparing the crude sevoflurane, chloromethyl hexafluoroisopropyl ether is reacted with a fluoride in the presence of a catalyst, pentaerythritol.

9. The preparation method according to claim 1, wherein the reaction solvent for preparing the crude sevoflurane is selected from one or more of polyethylene glycol, sulfolane or water.

10. The preparation method according to claim 1, wherein include: 1) Hexafluoroisopropanol, aluminum chloride and paraformaldehyde are mixed to prepare chloromethyl hexafluoroisopropyl ether; 2) reacting chloromethyl hexafluoroisopropyl ether with potassium fluoride and pentaerythritol to obtain a product, and separating the product by distillation to prepare crude sevoflurane; 3) Mixing the crude sevoflurane with sodium aluminosilicate molecular sieve having a silicon-to-aluminum ratio greater than 200, and then separating to obtain the finished sevoflurane product.

Citation Information

Patent Citations

  • Sevoflurane synthesizing method

    CN101381289A

  • Method for preparing sevoflurane

    CN102199076A

  • Preparation method of sevoflurane

    CN103804151A

  • Preparation method of chloromethyl hexafluoroisopropyl ether

    CN108689808A

  • Process for the purification of (hydro)halocarbons

    CN1751011A

Cited By

  • Industrial preparation method of sevoflurane

    CN120025235A

  • Industrial preparation method of sevoflurane

    CN120025235B